The glaucoma intensive treatment study: interim results from an ongoing longitudinal randomized clinical trial.

Boel Bengtsson Christina Lindén Anders HeijlSabina Andersson-GeimerJohan AspbergGauti Jóhannesson

Published in: Acta ophthalmologica (2021)

The rate of disease progression was significantly slower in the multi-treated patients than in the mono-treated patients. Further follow-up will show whether this difference is sustained over time.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
cross sectional
combination therapy